BIOFORCE NANOSCIENCES HOLDINGS, INC.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $238.7K | $-102.4K | $-115.9K | $-122.8K | $-935.5K | $-122.0K | $-114.4K | $-130.8K |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | — | $7.1K | — | — | $-15.2K | — | — | $-17.6K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $-1.5K | — | — | $28.2K | — | — | $17.6K |
| Net Change in Cash | — | $5.6K | — | — | $12.9K | — | — | $2 |
| Free Cash Flow | — | — | — | — | — | — | — | — |
Invert, always invert.